c-erbB-2 oncoprotein assay in ovarian carcinoma and its clinical correlation with prognostic factors

Cancer Letters

Volumn 132, Issue 1-2, 1998, Pages 91-97

  Kim, Young Tae ^a   Kim, Jae Wook ^a   Lee, Jung Woon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

c erbB 2 oncoprotein; Enzyme immunoassay; Ovarian cancer

Indexed keywords

ONCOPROTEIN;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE C ERB; OVARY CARCINOMA; OVARY CYST; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; CARCINOMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PELVIS; PROGNOSIS; RECEPTOR, ERBB-2;

EID: 0032561284     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00162-1     Document Type: Article

References (34)

1. Hynes N.E., Stern D.F. The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta. 1198:1994;165-184.
2. Cowley G.P., Smith J., Gusterson B.A. Increased epidermal growth factor receptors on human squamous carcinoma cell lines. Br. J. Cancer. 53:1986;223-229.
3. Fisher D.A., Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr. Rev. 11:1990;418-422.
4. King R.C., Draus M.H., Aaronson S.A. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science. 229:1985;974-976.
5. Coussens L., Yang-Feng T.L., Liao Y.U., Chen L., Gray A., McGrath J. Tyrosine-kinase receptor with extensive homology to EGF receptor shares chromosomal location with new oncogene. Science. 230:1985;1132-1139.
6. Bargmann C.I., Hung M.C., Weinberg R.A. The new oncogene encodes an epidermal growth factor receptor-related protein. Nature. 319:1986;226-230.
7. Schechter A.L., Stern D.F., Vaidyanathan L. The neu oncogene: an erb-B-related gene encoding a 185 000-M tumor antigen. Nature. 312:1984;513-519.
8. Shih C., Padhy L.C., Murray M., Weinberg R.A. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature. 290:1981;261-267.
9. Padhy L.C., Shih C., Cowing D., Finkelstein R., Weinberg R.A. Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell. 28:1981;865-871.
10. Yamamoto T., Ikawa S., Akiyama T., Semba K., Nomura N., Miyajima N., Sait T., Toyoshima K. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature. 319:1986;230-234.
11. Akiyama T., Sudo C., Ogawa H., Totoshima K., Yamamoto T. The product of the human c-erbB-2 gene: a 185 kilodalton glycoprotein with tyrosine kinase activity. Science. 232:1986;1644-1646.
12. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Lenin W.J., Stuart S.G., Udove H., Ullrich A., Press M.F. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science. 244:1989;707-712.
13. Press M.F., Jones L.A., Godolphin W., Edwards C.L., Slamon D.J. Her-2/neu oncogene amplification and expression in breast and ovarian cancers. Prog. Clin. Biol. Res. 354A:1990;209-221.
14. Berchuck A., Kamel A., Whitaker R., Kerns B., Olt G., Kinney R., Soper J.T., Dodge R., Clarke-Pearson D.L., Marks P., McKenzie S., Yin S., Bast R.C. Jr. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res. 50:1990;4087-4091.
15. Felip E., Lampo J.M.D., Rubio D., Vidal M.T., Colomer R. Overexpression of c-erbB-2 in epithelial ovarian cancer-prognostic value and relationship with response to chemotherapy. Cancer. 75:1995;2147-2152.
16. Haldane J.S., Hird V., Hughes C.M., Gullick W.J. c-erbB-2 oncogene expression in ovarian cancer. J. Pathol. 162:1990;231-237.
17. Kacinski B., Mayer A.G., King B.L., Carter D., Chambers S.K. NEU protein overexpression in benign, borderline, and malignant ovarian neoplasms. Gynecol. Oncol. 44:1992;245-253.
18. Shingleton T.P., Perrone T., Oakley G., Niehans G.A., Carson L., Cha S.S., Strickler J.G. Activation of c-erbB-2 and prognosis in ovarian carcinoma. Cancer. 73:1994;1460-1466.
19. Kim J.W., Kim Y.T., Kim D.K., Song C.H., Lee J.W. Expression of epidermal growth factor receptor in carcinoma of the cervix. Gynecol. Oncol. 60:1996;283-287.
20. Lowry O.H., Rosebrough N.J.J., Farr A.L. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-269.
21. Nugent A., McDermott E., Duffy K., O'Higgins N., Fennelly J.J., Duffy M.F. Enzyme-linked immunosorbent assay of c-erbB-2 oncoprotein in breast cancer. Clin. Chem. 38:1992;1471-1474.
22. Jukushige S.I., Matsubara K.I., Yoshida M. Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol. Cell. Biol. 6:1986;955-961.
23. Semba K., Kamata N., Toyoshima K., Yamamoto T. A c-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc. Natl. Acad. Sci. USA. 82:1985;8497-8502.
24. DiFiore P.P., Pierce J.H., Kraus M.H., Segatto O., King C.R., Aaronson S.A. ErbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science. 237:1987;178-182.
25. Sasano H., Garrett C.T., Wilkinson D.S., Silverberg S., Comerford J., Hyde J. Protooncogene amplification and tumor ploidy in human ovarian neoplasms. Hum. Pathol. 21:1990;382-391.
26. Mileo A.M., Fanuele M., Battaglia F., Scambia G., Benedetti-Panici C., Mattei E. Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries. Int. J. Biol. Markers. 7:1992;47-51.
27. Tal M., Wetzler M., Josefberg Z., Deutch A., Gutmar M., Assaf D. Sporadic amplification of the HER2/neu protooncogene in adenocarcinomas of various tissues. Cancer Res. 48:1988;1517-1520.
28. Natali P.G., Nicotra M.R., Bigotti A., Benturo I., Slamon K.J., Fendly B.M., Ullrich A. Expression of the p185 encoded by HER2 oncogene in normal and transformed human tissues. Int. J. Cancer. 45:1990;457-461.
29. Chang K., Ding I., Kern F.G., Willingham M.C. Immunohistochemical analysis of p53 and HER-2/neu proteins in human tumors. J. Histochem. Cytochem. 39:1991;1281-1287.
30. Gallion H.H., Powell D.E., Smith L.W., Morrow J.K., Martin A.W., vanNagell J.R., Donaldson E.S. Chromosome abnormalities in human epithelial ovarian malignancies. Gynecol. Oncol. 38:1990;473-477.
31. Seidman J.D., Frisman D.M., Norris H.J. Expression of the HER-2/neu proto-oncogene in serous ovarian neoplasms. Cancer. 70:1992;2857-2860.
32. vanDam P.A., Lowe D.G., Watson J.V., James M., Chard T., Hudson C.N., Shepherd J.H. Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract. Gynecol. Oncol. 42:1991;256-264.
33. Hung M.C., Zhang X., Yan D.H., Zhang H.Z., He G.P. Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer. Cancer Lett. 61:1992;95-103.
34. Rubin S.C., Finstad C.L., Wong G.Y., Almadrones L., Plante M., Lloyd K.O. Prognostic significance of HER-2/neu expression in advanced epithelial ovarian cancer; a multivariate analysis. Am. J. Obstet. Gynecol. 168:1993;162-169.